ABSTRACT
INTRODUCTION
Inserting an epitope tag into a protein facilitates the characterization of the protein when an antibody against it is unavailable. Various methods have been described over the last seven years (1, 5, 11, 12) . However, these methods usually depend upon the availability of unique restriction sites for the insertion of an epitope tag. To circumvent these difficulties, we have explored the use of a recombination polymerase chain reaction (PCR) method to simultaneously define a new linear epitope and conveniently insert the nucleotides encoding the desired epitope into an open reading frame (ORF) regardless of restriction sites.
The epitope mapping and tagging system was developed as part of a study of the antigenic determinants of varicella-zoster virus (VZV). VZV gL was previously shown to be a glycoprotein, but there was no monoclonal antibody (MAb) that bound to this gene product (3, 4) . Since the N terminus of a glycoprotein often contains a signal peptide that is cleaved when the protein enters the endoplasmic reticulum (13) , an epitope tag could not be inserted at the N terminus of gL. In addition, previous mutational analysis had demonstrated that the secondary structure of the Cterminus cannot be altered (3) . Therefore, the available N-terminal and Cterminal tagging techniques were not ideal for this protein. To continue the gL characterization, we first defined a linear epitope on an unrelated but highly immunogenic VZV glycoprotein called gE; the epitope called 3B3 is known to be remarkably resistant to denaturation (6,9). Then we formulated a strategy to insert this 3B3-epitope tag into gL using a recombination PCR mutagenesis method (7, 15) . The latter method allows insertion anywhere in the gL ORF. Finally, we documented the specificity of MAb 3B3 for the 3B3-epitope-tagged gL protein by precipitation and, ultimately, confocal microscopy. The recombination PCR method of epitope tagging has wide applicability to systems other than VZV proteins. (3, 6) .
MATERIALS AND METHODS

Restriction
MAb 3B3 Epitope of VZV Protein gE
VZV glycoprotein gE is the predominant immunogen of this herpesvirus; gE was formerly called gpI or gp98 (6, 9, 14) . The VZV gE gene was excised from the plasmid pTM1-VZV gE (pTM1-ORF 68) by restriction digestion with Sac I and Spe I (10, 14) . After separation by agarose gel electrophoresis, the 1.8-kb VZV gE DNA band was cut from an agarose gel and purified with a GENECLEAN ® Kit (Bio 101, Vista, CA, USA). DNase I (diluted 1:133, 1:200, 1:300 and 1:450) was utilized to randomly cleave gE into multiple fragments as part of the DNase Shotgun Cleavage Kit. The cleavage products were analyzed on a 2% agarose gel. All DNA bands from 50 bp to 150 bp were cut from the gel and electroeluted with a Gel Eluter (Hoefer Pharmacia Biotech, San Francisco, CA, USA). DNA extraction and recovery were performed as described in the Shotgun Cleavage Kit protocol. Residue overhang regions on the double-stranded DNA (dsDNA) fragments were converted to form blunt ends, and a single adenine residue was added to the 3 ′ ends of all fragments with the Single dA Tailing Kit; the dsDNA fragments were ligated into the pTOPE TVector using the protocol dictated by the Novatope System. Using the same protocol, the transformation was performed by adding 2.5 µ L of the ligation reaction to 50 µ L of NovaBlue (DE3) Competent cells. The resulting colonies were lifted onto round nitrocellulose filters (Millipore, Bedford, MA, USA).
Screening of the filters was carried out as described in the Colony Finder Immunoscreening Kit. The primary antibody was MAb 3B3. The secondary antibody was goat anti-mouse alkaline phosphatase conjugate. Four positive bacterial clones were isolated and screened with PCR primers supplied by the NovaTope System: T7 gene 10 Primer and T7 Termination Primer. DNA sequencing was performed with an automated fluorsecent sequencer at the University of Iowa DNA Core Facility ( Table 1) .
Preparation of Lysates and Chemiluminescent Dot Blot Assay
The two shortest clones were selected to produce lysates for blotting (clones 6B1 or 6B2). Lysates were prepared by using cells containing 6B1 or 6B2 to individually inoculate 4-mL cultures of CircleGrow ® broth (Bio 101), which were then incubated at 37°C overnight in an orbital shaker (225 rpm). The next day, clones 6B1 and 6B2 were induced to produce protein with ( 
Recombination Site-Specific PCR Insertional Mutagenesis
Cloning of the pTM1-VZV gL (pTM1-ORF 60) plasmid was previously described in detail (3). In separate reactions the plasmid pTM1-VZV gL was digested with either Nco I or Spe I to obtain two distinct linear species. These two linearized forms of pTM1-VZV gL served as templates for PCR mutagenesis, with MP16/P3 primers in one reaction and MP15/P4 primers in a second reaction ( Table 2 ). The two non-mutating primers P3 and P4 (Table 2) were located within the ampicillin resistance gene in the pTM1 vector (3, 15) . The PCR amplification was performed with the Expand ™ Long Template PCR System (Boehringer Mannheim, Indianapolis, IN, USA) as directed by the Expand protocol, with the following parameters: 94°C denaturation for 30 s, 40°C annealing for 30 s, 68°C extension for 4 min; after 25 cycles, there was a final extension at 72°C for 7 min. The PCR products were detected by ethidium bromide staining in a 1.2% agarose gel, then cleaned with an Ultrafree ™-MC filter (Millipore). The PCR products were combined and co-transformed into MAX Efficiency DH5 αCompe -tent Cells (3, 7, 15) . Eighteen colonies were individually grown in 3-mL aliquots of CircleGrow broth overnight at 37°C in an orbital shaker. The clones were screened by PCR amplification of gL sequences using amplification primers P1 and P2 (Table 2) , which flank the gL gene within pTM1-VZV gL (3). Five randomly chosen gL-positive clones were digested with Bst NI, at the unique restriction site created by the mutagenesis, to confirm the presence of the inserted sequence. Plasmid purification was carried out with a QIA-GEN ® Maxi Kit (Qiagen, Chatsworth, CA, USA). The plasmid was designated pTM1-VZV gL3B3.8. Sequencing with sequencing primer 2 (SP2), found within the anti-sense strand of the gL gene (Table 2) , was performed at the University of Iowa DNA Core Facility.
In subsequent experiments, the plasmid pTM1-VZV gL3B3.8 was digested in separate reactions with the restriction enzymes Nco I and Spe I to give two linear species. These two linearized forms served as templates for the PCR insertional mutagenesis with primers MP20/ P3 and primers MP19/P4, respectively ( Table 2 ). The PCR amplification was performed under previously described conditions (3). The PCR parameters were the same as described in the gL3B3.8 mutagenesis. The PCR products were co-transformed into MAX Efficiency DH5 αCompetent Cells. Ten colonies were individually grown in 3-mL CircleGrow broth cultures at 37°C overnight. The clones were screened by PCR amplification of gL sequences with amplification primers P1 and P2, as described above. Five randomly chosen positive clones were digested with Mbo I at the unique restriction site created by mutagenesis. The Mbo I site is located in primers MP19 and MP20 (Table 2) . After plasmid purification, the existence of the gL3B3.11 mutant was confirmed by sequencing.
Analysis by Polyacrylamide Gel Electrophoresis (PAGE) and Confocal Microscopy
The gL3B3.11 DNA and wild-type gL DNA were transfected into HeLa cells (CCL2; ATCC, Rockville, MD, USA) in the presence of 15% Lipofectin Reagent, as previously described (3, 14) . The cells were labeled for 18 h with 250 µ Ci/mL ofL - [4,5- 
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Chemical, St. Louis, MO, USA) containing 10% fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT, USA). VZV gH contains 60 leucine residues, and VZV gL contains 11 leucine residues. Lysates were prepared prior to immunoprecipitation with MAb 3B3 or R-60 (rabbit antiserum against gL) (3,4) . The precipitates were analyzed by 10%-18% gradient sodium dodecyl sulfate (SDS)-PAGE under reducing conditions. The dried gels were exposed to radiographic film for 5-30 days.
For microscopy, transfected cells were incubated overnight in Eagle medium (MEM; Sigma Chemical) with 10% FBS supplemented with glutamate, nonessential amino acids and penicillin/ -streptomycin. Cell monolayers were fixed with 2% paraformaldehyde, permeabilized with 0.05% Triton ® X-100 and blocked with 5% normal goat serum (NGS) (3). The monolayers were incubated with the primary antibody (MAb 3B3), then with the secondary antibody (goat anti-mouse Ig FITC conjugate) (BioSource International, Camarillo, CA, USA). All samples were analyzed by laser scanning confocal microscopy (Bio-Rad) (3).
RESULTS AND DISCUSSION
Initial Mapping of the MAb 3B3 Epitope
The NovaTope System initially mapped the MAb 3B3-epitope to a region of gE between amino acid residues 131-164; the deduced amino acid sequences of the four clones are shown in Table 1 . The products of the two shortest clones, 6B1 (21 residues) and 6B2 (24 residues), were screened by chemiluminescent dot blotting. The intensity of the clone 6B1 product was less than that of the clone 6B2 product (data not shown). The only difference between the 6B1 and 6B2 products was three additional C-terminal amino acid residues in clone 6B2 (159-161; KGD), while the remaining residues within 6B1 and 6B2 were identical (138-158) ( Table  1) . Since the presence of the three Cterminal residues of 6B2 seemed to influence the expression or presentation of the predicted epitope, the position of the epitope was considered to be C-terminally within both clones. In order to determine the smallest possible epitope, the last eight amino acid residues of 6B1 (3B3.8; QRQYGDVF) were initially inserted into VZV gL by a recombination site specific PCR insertional mutagenesis method (Figure 1 , panel A). For this procedure, the combination of MP16/P3 (reaction 1) and MP15/P4 (reaction 2) inserted 24 nucleotides (3B3.8) into wild-type pTM1-VZV gL immediately downstream from codon 21. The site of insertion was based on unpublished data by the authors that showed that mutagenesis at position 21 had little effect on gL function. Primer MP15 was designed to incorporate a new restriction site, BstN1, into the mutated plasmid for efficient screening of positive clones ( Table 2 ). The asterisks in Figure 1 denote the position of the non-mutating PCR primers P3 and P4, which complement an overlapping portion of the ampicillin-resistance gene within pTM1 (Table 2) (3, 15) .
Recombination site-specific PCR insertional mutagenesis of the linearized plasmid pTM1-gL (6.2 kb) was performed with the Expand Long Template PCR System. Two PCRs with paired primers MP15/P4 and MP16/P3 produced two linear products of 2.8 and 3.4 kb, respectively. Both PCR products were cleaned with an Ultrafree-MC filter then co-transformed into MAX Efficiency DH5 αCompetent Cells ( Figure  1B ). Eighteen colonies were picked and screened by PCR amplification of gL with amplification primers P1 and P2 (Table 2) as described (3) . Agarose gel electrophoresis demonstrated that 16 of 18 amplified PCR clones were positive for gL sequences. Five gL-positive clones were randomly chosen and digested with Bst N1 to confirm the presence of the 24-bp inserted sequence. Plasmid DNA from one clone, pTM1-gL3B3.8 ( Figure 1C) , was isolated and sequenced.
Cell lysates containing the gL3B3.8 product were harvested from HeLa cells, then blotted with or precipitated by MAb 3B3 and rabbit antibody R-60. The expressed protein was recognized by the gL antiserum R-60 but not by MAb 3B3 (data not shown). Thus, the 3B3 epitope had been incompletely reconstructed in our first set of experiments.
Epitope Tagging of VZV gL
A review of the data in Table 1 suggested that the three additional amino acids (KGD) present in gE peptide clone 6B2 may be essential for MAb 3B3 recognition. Therefore, an additional PCR insertional mutagenesis experiment was performed with the gL3B3.8 construct as the template. Panel D of Figure 1 illustrates the recombination PCR insertional mutagenesis strategy with MP20/P3 (reaction 3) and MP19/P4 (reaction 4). This procedure inserted 9 nucleotides (3B3.3) into pTM1-gL3B3.8 immediately downstream from the 3B3.8 insertion. The 5 ′ end of MP19 and the 3 ′ end of MP20 complemented a portion of the previous 3B3.8 insertion.
Recombination site-specific PCR insertional mutagenesis of plasmid pTM1-gL3B3.8 (6.2 kb) was performed under the same conditions and parameters as described above. The 3B3.3 insertion, however, utilized paired primers MP19/P4 and MP20/P3, which produced two linear products of 2.8 and 3.4 kb, respectively. Both PCR products were co-transformed into MAX Efficiency DH5 α Competent Cells. Ten colonies were picked and screened by PCR amplification of gL with primers P1 and P2, as described (3) . Agarose gel electrophoresis demonstrated that 8 of 10 amplified PCR clones were positive for gL sequences. Five gL-positive clones were 334BioTechniques
Vol. 22, No. 2 (1997) randomly chosen and digested with Mbo I. The Mbo I site is located within primers MP19 and MP20 ( Table 2) . The plasmid DNA of one clone was isolated and sequenced; this plasmid, designated pTM1-gL3B3.11, contained the 11-codon 3B3-epitope (QRQ-YGDVFKGD) inserted into the gL gene ( Figure 1E ).
Immunoprecipitation of gL-3B3
In the VZV-infected cell, gL functions as a chaperone protein for and complexes with glycoprotein gH (3,4) . Therefore, immunoprecipitation analyses were carried out with single (gL alone) and dual (gL/gH) transfections. Lysates of gL-3B3.11-and gH/gL- Table 2 .
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3B3.11-transfected cells were precipitated with MAb 3B3 and R-60, and then analyzed by 10%-18% gradient SDS-PAGE. MAb 3B3 recognized the 3B3-epitope tag and precipitated gL-3B3 from both lysates (Figure 2 ; lanes 3 and 5). The gL-3B3 mutant (lanes 2-5) had an Mr = 21 000, which is slightly larger than wild-type gL ( Mr = 20 000) (3, 4) . This result affirmed the presence of the 11 amino acid 3B3-epitope tag within the gL-3B3 protein. In addition, gL-3B3 appeared to be associating with gH, as indicated by comparing lysates containing gH and gL-3B3 precipitated by R-60 and MAb 3B3 (lanes 4 and 5). Thus, gH/gL-3B3 associated in a manner similar to the wild-type gH/gL products (3, 4) . The negative immunoprecipitation control included T7-vaccinia virus and R-60 antiserum (lane 1) (3, 15) . Published results have already demonstrated that wild-type gL is not precipitated by MAb 3B3 (6,9) and gH alone is not precipitated by R-60 serum (3).
Intracellular Localization of gL-3B3
Intracellular localization was investigated by a MRC-600 laser scanning confocal microscope (Bio-Rad). The confocal microscope is especially beneficial due to its ability to optically slice through the cell and define protein localization within individual organelles. To date, trafficking of gL has been impossible to study because the rabbit antiserum elicits a high background of nonspecific fluorescence. To avoid this problem, HeLa cells were transfected with gL3B3.11 DNA, incubated with MAb 3B3 and then with a FITC-labeled goat anti-mouse secondary antibody, as described (3). The cell monolayer was fixed and made mildly permeable to facilitate MAb 3B3 binding to gL-3B3 inside the cell. When examined by confocal microscopy, large amounts of fluorescence were observed within cells expressing gL-3B3 (Figure 3 ). The cell nucleus was negatively outlined by the abundant perinuclear staining. The positive staining pattern was characteristic of that seen with other viral glycoproteins synthesized within the endoplasmic reticulum (6, 8, 9) . There was no diffuse staining throughout the cytoplasm, nor was there any staining of the outer cell 336BioTechniques
Vol. 22, No. 2 (1997) Figure 2 . Electrophoretic analysis of gL-3B3. Radiolabeled lysates of VZV gL-3B3.11-and gH/gL-3B3.11-transfected cells were precipitated with MAb 3B3 and R-60; the precipitates were subjected to SDS-PAGE as described in Materials and Methods. Lane 1 contains the T7-vaccinia virus negative control sample precipitated with anti-gL rabbit antiserum R-60. Lanes 2 and 3 contain a VZV gL-3B3 antigen sample precipitated with R-60 and MAb 3B3, respectively. Lanes 4 and 5 contain a gH/gL-3B3 cotransfection antigen sample precipitated with R-60 and MAb 3B3, respectively. As previously described (3), an antibody that precipitates gL will co-precipitate gH from co-transfected lysates (lanes 4 and 5). All precipitates were analyzed in the same gel, but lane 5 was exposed for a longer period. Molecular mass marker proteins (Amersham) are indicated along right margin. (Figure 3) . In other words, the gL glycoprotein was restricted to the endoplasmic reticulum. This result was unexpected since the major VZV glycoproteins, such as gE, quickly exit the endoplasmic reticulum/Golgi and travel to the outer cell membrane where they are easily detectable (6) . In summary, we have fine-mapped an 11-amino-acid linear epitope on VZV gE by recombination PCR. At the same time, we have inserted this epitope into another protein called VZV gL and demonstrated that the tagged gL protein can be easily identified by both immunoprecipitation and immunofluorescence. This characterization of gL would not have been possible without epitope tagging at a noncritical site. Recombination site-specific PCR insertional mutagenesis greatly expands the applicability of epitope mapping and tagging technology. One special advantage is the capacity to epitope tag a gene of interest within virtually any expression plasmid without the need to first shuttle the gene or to consider the availability of unique restriction sites (15) . 
